JoVE Logo

Zaloguj się

Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.

W tym Artykule

  • Podsumowanie
  • Streszczenie
  • Wprowadzenie
  • Protokół
  • Wyniki
  • Dyskusje
  • Ujawnienia
  • Podziękowania
  • Materiały
  • Odniesienia
  • Przedruki i uprawnienia

Podsumowanie

Dunkin-Hartley guinea pigs are an established animal model for osteoarthritis research. Such studies may benefit from intra-articular injections for various reasons, including investigating novel agents or treating disease. We describe a methodology for intra-articular knee injections in Guinea pigs and subsequent micro-computed tomography analysis assessing arthritis-associated knee changes.

Streszczenie

The purpose of this protocol is to guide researchers in performing a palpation-guided technique of intra-articular knee injection in guinea pigs and assessment using micro-computed tomography. Dunkin-Hartley guinea pigs are robust models for osteoarthritis research as they spontaneously develop osteoarthritis in their knees. Intra-articular drug delivery is a common method to study the effects of an investigational drug in vivo. In humans, therapeutic agents administered via intra-articular injection can offer pain relief and delay further progression of osteoarthritis. As with any species, the introduction of a needle into a joint space has the potential to cause injury, which can result in pain, lameness, or infection. Such adverse events can compromise animal welfare, confound study results, and necessitate additional animals to achieve study objectives. As such, it is imperative to develop proper injection techniques to prevent complications, especially in longitudinal studies that require multiple, repeated intra-articular injections. Using the presented methodology, five guinea pigs received bilateral knee injections under general anesthesia. Seven days after injection, animals were humanely euthanized for analysis of osteoarthritis severity. No adverse events occurred following anesthesia or knee injections, including limping, pain, or infection. X-ray micro-computed tomography analysis of the knee can detect pathologic changes associated with osteoarthritis. Micro-computed tomography data indicates osteoarthritis is more severe in older animals, as indicated by increased bone mineral density and trabecular thickness with age. These results are consistent with histologic changes and Modified Mankin scores, an established and widely used scoring system to assess arthritis severity in these same animals. This protocol can be utilized to refine intra-articular injections in guinea pigs.

Wprowadzenie

Osteoarthritis (OA) impacts 32.5 million US adults. It is caused by progressive loss of articular cartilage, mild inflammation of the tissues in and around the joints, and formation of osteophytes and bone cysts1,2. Symptoms typically manifest in the later stages of the disease, with current treatments providing only palliative relief as well as having systemic side effects. The lack of disease-modifying drugs stems from a poor understanding of the underlying mechanisms of the disease3. As a result, there is a critical and ongoing medical need for improved agents to treat OA.

Several animal models of OA are available that examine different components of the disease processes4. While several surgical models exist, including transection of the anterior cruciate ligament and destabilization of the medial meniscus, these are invasive and require a high level of technical skill5. Chemically induced models are comparatively less invasive procedures typically used to study OA pain mechanisms6. One such widely used mouse model involves OA induction by an intra-articular knee injection of monosodium iodoacetate (MIA). This model generates a reproducible, robust, and rapid pain-like phenotype that can be graded by altering MIA dosage7. Technical details of inducing this model have been previously described7. Translation of this technique to larger rodents, like guinea pigs, is difficult due to their anatomical differences. Some differences include increased musculature surrounding the adjacent bones and joint space in the guinea pig and an articulating fibula and tibia compared to distal fusion seen in mice8. Dunkin-Hartley guinea pigs, a widely available guinea pig strain, are an established OA animal model as they naturally develop this disease, thereby offering a robust model for investigating the effects of novel therapeutics administered by intra-articular injection on disease progression9. Dunkin-Hartley guinea pigs start developing OA at three months, with males displaying an accelerated development and more severe phenotype10. In guinea pigs, OA progresses with age, and at 12 months, associated pathology is apparent on imaging11. Spontaneous OA models, like the Dunkin-Hartley model, do not require any intervention to induce OA and thus recapitulate the development and progression of the disease phenotype in humans, thereby providing a powerful translational model10. Furthermore, the spontaneous development of OA allows for the internal control when novel therapeutics are administered unilaterally in a single knee of a given animal. This internal control minimizes the effects of inter-animal variabilities when analyzing data and may help reduce overall animal numbers.

X-ray Micro Computed Tomography (µCT) analysis is a powerful tool that allows for quantitative assessment of OA severity12. µCT involves scanning multiple, high-resolution X-ray images, obtained from a rotating sample or rotating X-ray source and detector13. Then, three- dimensional (3D) volumetric data is reconstructed in the form of stacked image slices14. Because mineralized bone has excellent contrast on µCT, this modality can be used to assess 3D features and perform quantitative analyses of changes associated with OA15,16,17. µCT offers several advantages over more widely used tools, including histopathology and gait analyses. In contrast to histologic assessment of one or few sections of tissues, µCT scans the entire joint and offers a more wholistic assessment of OA lesions18. While gait analysis can discern symptomatic changes in joint function over time, joint changes develop long before functional changes associated with OA. µCT can provide a more sensitive measure of OA development prior to the onset of lameness. Two particularly relevant quantitative measurements include bone mineral density and trabecular thickness as both increase throughout the progression of OA19,20. It can be helpful to split the analysis into subchondral plate and trabecular bone, as they have different features, to achieve more robust measurements and comparisons.

The overall goal of this method is to help researchers successfully perform intra-articular injections on guinea pigs. The presented protocol utilized five-(n=2), nine- (n=1), and 12- (n=2) month-old intact, male Dunkin-Hartley guinea pigs; procedures can be extrapolated to other guinea pig strains and ages requiring intra-articular knee injections. In spontaneous models of OA, like the Dunkin-Hartley model, disease progression and response to serial treatment is often monitored over long periods of times, spanning weeks to months9. This extended protocol results in multiple intra-articular injections, and thus it is important to have proper injection technique to prevent adverse events, including pain, lameness, or infections, all of which can impact animal welfare and confound study results while necessitating additional animals on study. The presented protocol describes methodology of intra-articular injections in guinea pigs and subsequent analysis of µCT data.

Protokół

All methods described here have been approved by the Institutional Animal Care and Use Committee of the Medical University of South Carolina. The study followed the principle of 3R.

1. Intra-articular injection preparations

  1. Allow Dunkin-Hartley guinea pigs to acclimate to facility for at least one week prior to starting the experiment.
    NOTE: 5- (n=2), 9- (n=1), and 12- (n=2) month-old male guinea pigs were used. Males display an accelerated development and more severe phenotype of OA.
  2. Shave the knee area with an electric razor.
    NOTE: Be careful of the nipples medially.
  3. Anesthetize guinea pig in an isoflurane chamber delivering 3-5% isoflurane in O2 mixture (flow rate 2.5 L/min) and then transfer the guinea pig to a nose cone connected to a non-rebreathing anesthesia circuit. Adjust isoflurane to maintain surgical plane of anesthesia during the injection, typically with an oxygen flow rate of 0.5-1 L/min and 1-3% isoflurane.
    NOTE: Intra-articular injections cause mild, momentary pain. Animals are anesthetized during the procedure to prevent perception of painful stimuli and improve injection accuracy. In the presented study, the administration of analgesic agents, including nonsteroidal anti-inflammatory drugs, would interfere with OA progression21. Due to the momentary pain, provided anesthesia and potential of analgesics to confound the model, analgesics were not administered unless animals displayed side effects, including limping and signs of pain on joint palpation after injection. Investigators should consider the use of analgesics for routine injections. Analgesics are recommended when side effects occur. Analgesic regimens should be discussed with the institutional veterinarian and approved by the IACUC prior to initiating studies.
  4. Ensure guinea pig is at appropriate anesthesia depth by lack of toe pinch response.
  5. Place sterile ocular lubricant on both eyes to prevent desiccation and injury.
  6. Dilute betadine with sterile water to 10%.
  7. Dilute 200 proof ethanol with sterile water to 70% ethanol.
  8. Prepare solutions for injection, in a biosafety cabinet to maintain sterility. In the presented protocol, a sterile vehicle (1x phosphate buffered saline) was utilized to inject both knees. Solutions can be changed based on research objectives.
    NOTE: Make sure to dilute fresh solutions for injection immediately before the injection session to ensure sterility. Any unused solutions should be discarded at the end of each injection session.
  9. Fill sterile one-time-use insulin syringes with solutions for injection. Take care to utilize the smallest volume achievable to prevent overloading the joint space with volume. In the present study, 50 µL was used.
  10. Place guinea pig and nose cone on a clean surface with a heating pad for thermal support and padding under the head to elevate it slightly.
  11. Don surgical gown, hair net, sterile gloves, and mask while performing the injection procedure.
  12. Pour 10% betadine onto a cotton ball and wipe both knee areas.
  13. Pour 70% ethanol onto a cotton ball and wipe both knee areas.
  14. Repeat 1.12 and 1.13 two more times.
    NOTE: For demonstration purposes, the corresponding video shows cleaning the knee and injection site once with 10% betadine and 70% ethanol. The injection site was subsequently cleaned using circular motions two more times, alternating these solutions. Three serial scrubs with alternating scrub solutions and alcohol are recommended to achieve aseptic technique.

2. Intra-articular injection

  1. Place the guinea pig in supine position for entirety of the procedure.
  2. Don a new pair of sterile gloves and palpate the knee joint.
    NOTE: In the presented protocol and video, autoclaved nitrile gloves were utilized. Sterile gloves, including either autoclaved nitrile gloves or surgical gloves, should be utilized for aseptic technique.
  3. Manually flex the knee to 90°.
  4. Move finger distal to the patella to locate the groove of the distal aspect of joint space by flexing and extending the hindlimb.
    NOTE: The patella can be palpated in this position as a small, firm structure located directly over the joint space. The tibia can be felt as a bony structure distal to the patella. Once the location of the tibia and patella are determined, the joint, felt as a groove, is between them, distal to the patella and proximal to the tibia.
  5. Insert the insulin needle carefully on the midline distal to the patella within the joint space. The needle should be inserted 1-2 mm below the skin to enter the joint space.
    NOTE: The largest access window for the joint space while the knee is flexed is on the anterior aspect of the limb on midline, directly distal to the patella. Injecting on midline in the anterior-to-posterior direction will aid in accurately injecting into the joint space without penetrating boney structures. Accurately injecting into the joint space can be achieved using a lateral-to-medial approach, although the access window is narrower especially when the knee is flexed.
  6. Inject 50 µL of the solution into the joint slowly. Ensure that the needle inserts easily, and contents are injected without resistance.
    NOTE: Make sure not to insert the needle too deep as it can cause joint or bone damage and result in unwanted inflammation and/or pain. If the groove corresponding to the joint space is not found, the needle could penetrate the femur, patella, or tibia. Therefore, it is beneficial to confidently palpate the groove corresponding to the joint space to prevent peri-articular injections or injuries associated with penetrating boney structures. If a bubble develops at the injection site under the skin, the injection was too shallow and the fluid has entered the subcutaneous space. Depending on the properties of the agent utilized, the drug may enter the joint space via diffusion, or another injection attempt may be needed.
  7. Once done discard the needle into sharps bin.
    NOTE: For practice and training purposes, inject liquid containing a dye into the joint space of a cadaver in a similarly sized rodent or guinea pig. Then, dissect the joint to confirm the location of the injection.
  8. Massage the knee by flexing and extending the joint a few times promote diffusion of the drug within the joint space.
  9. Repeat steps 2.1-2.5 once on the contralateral limb with 1x PBS solution.

3. Recovery from intra-articular injection

  1. Turn off isoflurane and maintain 100% flow by oxygen until the animal regains consciousness.
  2. Place the animal on a heating pad for thermal support until ambulatory.
  3. Apply an ice pack to the knee for 30 s with a paper towel as a barrier to help decrease swelling from the injection.
  4. Assess animal gait when ambulatory prior to returning them to housing.
    NOTE: If any gait abnormalities are noted, analgesics and supportive care may be warranted. It is advisable to assess their gait again several hours after recovery from anesthesia to ensure normal mobility.

4. Micro computed tomography (µCT) scan

  1. For the tissue harvest, establish a surgical plane of anesthesia with 100% oxygen and 5% isoflurane mixture.
  2. Confirm a surgical plane of anesthesia with the lack of response to a toe-pinch stimulus. Humanely euthanize the animal via administration of ≥ 150 mg/kg of pentobarbital intravenously according to institutional policies and approved animal use protocol.
    NOTE: In the presented protocol, each of the five guinea pig received one injection in both knees. Animals were anesthetized and humanely euthanized one week after the injection.
  3. Harvest both hindlimbs by dissecting the skin away from the surrounding musculature.
  4. Next, disarticulate the hindlimb with Rongeurs at the mid-shaft of the femur and proximal to the ankle.
    NOTE: The scanning bed and specimen holder used was unable to accommodate the entire hindlimb of an adult guinea pig. Large specimen holders are commercially available for larger specimen sizes.
  5. Place the tissues in neutral buffered formalin solution for 72 h for fixation before performing µCT.
  6. Open µCT scan software and place sample with formalin in a compatible container that will fit into the µCT specimen folder while maintaining tissue in the field of vision.
  7. Calibrate µCT machine for dark field and light field exposures according to manufacturer recommendations.
  8. Scan the sample with Al+Cu filter at 18 µm. Use rotation step 0.7° for 360° with offset camera.
    NOTE: The scan automatically saves.

5. Image processing for evaluating bone microarchitectural parameters

  1. Download and install µCT reconstruction software for the reconstruction of µCT images.
  2. Select the software folder and double click to open the software.
  3. Select one slice from the µCT images by clicking on an image slice.
  4. Choose the reconstruction file destination. Select Browse and create a new folder named Recon. The selected file format should be BMP(8).
  5. Check Misalignment Compensation.
    NOTE: Usually, the estimation is close to correct, but it can be manually adjusted to shift the overlapping images so that the right and left edges align as closely as possible.
  6. Under Settings, apply Smoothing, Beam Hardening, CS Rotation, and Ring Artifacts algorithms.
    NOTE: It can be helpful to choose preview image to determine the clarity before reconstructing. The fine-tuning setting can also be helpful to determine which settings are the best.
  7. Select Start to begin processing the reconstruction.

6. Collection of microarchitectural data from reconstructed images

  1. Download and install Dataviewer.
  2. Select VOI and orient the sample to align vertically for easier analysis at a later time.
  3. Save edited VOI as a new folder.
  4. Download and install CTAnalyser for the bone property analysis of microarchitectural parameters.
    NOTE: The free version of CTAnalyser is limited in functionality, so is recommended to obtain a full license.
  5. Split the analysis to subchondral plate and trabecular bone by saving them as separate range of images.
    NOTE: Splitting the analysis is not necessary, but because subchondral plate and trabecular bone have different features, separate analyses can assist with robust measurements and comparison.
  6. Select the range of images to analyze, starting with subchondral plate by clicking on the image slice that you want to start with.
  7. Select the region of interest for each image to ensure that it is encompassing the bone by clicking on the region of interest tab.
  8. Select the Binary Selection tab. Adjust the histogram so that the background and the bone is completely separate.
  9. Select the Bone Mineral Density (BMD) tab. Save that data into a new analysis data folder.
  10. Select Custom Processing and go to Internal tab.
  11. First perform Thresholding and select Automatic Otsu, then Run.
  12. Then select Despeckle and choose Remove black speckles, then Run.
  13. Repeat Despeckle and choose Remove white speckles, then Run.
  14. Choose 3D analysis and select Basic values and Additional values.
  15. Repeat steps 6.2.2-6.4.5 to reset the image for trabecular bone analysis.
    NOTE: Make sure the output file is in a new folder with the same file as the BMD data.

Wyniki

Before performing intra-articular injections on live animals, the above protocol was practiced on three rat cadavers to ensure correct injection location. During the practice sessions, 50 µL of 70% new methylene blue dye was injected into both knee joints using the methodology described above. This equates to six practice injections. After injections, the knee joint was dissected by incising through the cranial aspect of the joint space, distal to the patella and through the patellar ligament, to visualize the joint...

Dyskusje

Despite recent advancements in symptomatic treatment of OA, there is a complete lack of therapeutic agents that prevent onset or delay progression of OA24. Currently, the only cure for severe OA is joint replacement, which is costly, invasive, and can result in patient morbidity and mortality25. As a result, there is a dire need for continued research with animal models of OA and the sustained development of novel therapeutics. Several animal models are available to study d...

Ujawnienia

None

Podziękowania

The research outlined in this manuscript was supported by South Carolina SmartState® Endowed Chair in Drug Discovery Endowment funds (PMW), the MUSC Division of Laboratory Animal Resources, and the MUSC Drug Discovery Core. This publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Grant Numbers TL1 TR001451 & UL1 TR001450, as well as the National Institute of Dental & Craniofacial Research of the National Institutes of Health under Award Number R01DE029637.

Materiały

NameCompanyCatalog NumberComments
200 Proof EthanolDecon Laboratories2701sterilizing agent
3D.SUITE softwareBrukerμ-CT analyzing software
Betadine Surgical ScrubAvrio Health67618-151-16sterilizing agent
Insulin syringe with needleUlticare91008to perform injections
IsofluranePiramal803249anesthesize animal
Neutral Buffered FormalinFisher Scientific23-427098Fix tissue
Nrecon SoftwareBrukerμ-CT reconstruction software
Phosphate Buffered SalineCytivaSH30258.01control and diluting agent
SkyScan 1176Brukerto scan samples 

Odniesienia

  1. Callahan, L. F., Cleveland, R. J., Allen, K. D., Golightly, Y. Racial/Ethnic, socioeconomic, and geographic disparities in the epidemiology of knee and hip osteoarthritis. Rheum Dis Clin North Am. 47 (1), 1-20 (2021).
  2. Mandl, L. A. Osteoarthritis year in review 2018: clinical. Osteoarthritis Cartilage. 27 (3), 359-364 (2019).
  3. Assirelli, E., et al. Complement expression and activation in osteoarthritis joint compartments. Front Immunol. 11, 535010 (2020).
  4. Lampropoulou-Adamidou, K., et al. Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol. 24 (3), 263-271 (2014).
  5. Glasson, S. S., Blanchet, T. J., Morris, E. A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage. 15 (9), 1061-1069 (2007).
  6. Kuyinu, E. L., Narayanan, G., Nair, L. S., Laurencin, C. T. Animal models of osteoarthritis: classification, update, and measurement of outcomes. J Orthop Surg Res. 11, 19 (2016).
  7. Pitcher, T., Sousa-Valente, J., Malcangio, M. The Monoiodoacetate Model of Osteoarthritis Pain in the Mouse. J Vis Exp. (111), e53746 (2016).
  8. de Araujo, F. A., et al. morphology of the hind limbs in two caviomorph rodents. Anat Histol Embryol. 42 (2), 114-123 (2013).
  9. Veronesi, F., Salamanna, F., Martini, L., Fini, M. Naturally occurring osteoarthritis features and treatments: systematic review on the aged guinea pig model. Int J Mol Sci. 23 (13), (2022).
  10. Kraus, V. B., Huebner, J. L., DeGroot, J., Bendele, A. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig. Osteoarthritis Cartilage. 18, S35-S52 (2010).
  11. Wang, S., et al. The osteoarthritis natural progress and changes in intraosseous pressure of the guinea pig model in different degeneration stages. Orthop Surg. 14 (11), 3036-3046 (2022).
  12. Boyde, A. The bone cartilage interface and osteoarthritis. Calcif Tissue Int. 109 (3), 303-328 (2021).
  13. Akhter, M. P., Recker, R. R. High resolution imaging in bone tissue research-review. Bone. 143, 115620 (2021).
  14. Clark, D. P., Badea, C. T. Advances in micro-CT imaging of small animals. Phys Med. 88, 175-192 (2021).
  15. Bouxsein, M. L., et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 25 (7), 1468-1486 (2010).
  16. Yang, D., et al. Involvement of CD147 in alveolar bone remodeling and soft tissue degradation in experimental periodontitis. J Periodontal Res. 52 (4), 704-712 (2017).
  17. Ruegsegger, P., Koller, B., Muller, R. A microtomographic system for the nondestructive evaluation of bone architecture. Calcif Tissue Int. 58 (1), 24-29 (1996).
  18. Boca, C., et al. Comparison of micro-CT imaging and histology for approximal caries detection. Sci Rep. 7 (1), 6680 (2017).
  19. Ren, P., et al. Biochemical and morphological abnormalities of subchondral bone and their association with cartilage degeneration in spontaneous osteoarthritis. Calcified Tissue International. 109 (2), 179-189 (2021).
  20. Wang, X., et al. Stage-specific and location-specific cartilage calcification in osteoarthritis development. Ann Rheum Dis. 82 (3), 393-402 (2023).
  21. Magni, A., et al. Management of osteoarthritis: expert opinion on NSAIDs. Pain Ther. 10 (2), 783-808 (2021).
  22. Wang, T., Wen, C. Y., Yan, C. H., Lu, W. W., Chiu, K. Y. Spatial and temporal changes of subchondral bone proceed to microscopic articular cartilage degeneration in guinea pigs with spontaneous osteoarthritis. Osteoarthr Cartil. 21 (4), 574-581 (2013).
  23. Gao, J., Ren, P., Gong, H. Morphological and mechanical alterations in articular cartilage and subchondral bone during spontaneous hip osteoarthritis in guinea pigs. Front Bioeng Biotechnol. 11, 1080241 (2023).
  24. Makarczyk, M. J., et al. Current models for development of disease-modifying osteoarthritis drugs. Tissue Eng Part C Methods. 27 (2), 124-138 (2021).
  25. Hunter, D. J. Pharmacologic therapy for osteoarthritis--the era of disease modification. Nat Rev Rheumatol. 7 (1), 13-22 (2011).
  26. Schuelert, N., McDougall, J. J. Grading of monosodium iodoacetate-induced osteoarthritis reveals a concentration-dependent sensitization of nociceptors in the knee joint of the rat. Neurosci Lett. 465 (2), 184-188 (2009).
  27. Yao, X., et al. Chondrocyte ferroptosis contribute to the progression of osteoarthritis. J Orthop Translat. 27, 33-43 (2021).
  28. Huebner, J. L., Hanes, M. A., Beekman, B., TeKoppele, J. M., Kraus, V. B. A comparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage. 10 (10), 758-767 (2002).
  29. Ringe, J., et al. CCL25-Supplemented hyaluronic acid attenuates cartilage degeneration in a guinea pig model of knee osteoarthritis. J Orthop Res. 37 (8), 1723-1729 (2019).
  30. Chouhan, D. K., et al. Multiple platelet-rich plasma injections versus single platelet-rich plasma injection in early osteoarthritis of the knee: An experimental study in a guinea pig model of early knee osteoarthritis. Am J Sports Med. 47 (10), 2300-2307 (2019).
  31. Patel, S., Mishra, N. P., Chouhan, D. K., Nahar, U., Dhillon, M. S. Chondroprotective effects of multiple PRP injections in osteoarthritis by apoptosis regulation and increased aggrecan synthesis- Immunohistochemistry based Guinea pig study. J Clin Orthop Trauma. 25, 101762 (2022).
  32. Cheng, J., Abdi, S. Complications of joint, tendon, and muscle injections. Tech Reg Anesth Pain Manag. 11 (3), 141-147 (2007).
  33. Wang, Q., et al. Identification of a central role for complement in osteoarthritis. Nat Med. 17 (12), 1674-1679 (2011).
  34. Santangelo, K. S., Kaeding, A. C., Baker, S. A., Bertone, A. L. Quantitative gait analysis detects significant differences in movement between osteoarthritic and nonosteoarthritic guinea pig strains before and after treatment with flunixin meglumine. Arthritis. 2014, 503519 (2014).
  35. McCoy, A. M. Animal models of osteoarthritis: comparisons and key considerations. Vet Pathol. 52 (5), 803-818 (2015).
  36. Thysen, S., Luyten, F. P., Lories, R. J. Targets, models and challenges in osteoarthritis research. Dis Model Mech. 8 (1), 17-30 (2015).
  37. Vazquez-Portalatin, N., Breur, G. J., Panitch, A., Goergen, C. J. Accuracy of ultrasound-guided intra-articular injections in guinea pig knees. Bone Joint Res. 4 (1), 1-5 (2015).
  38. Nie, C., Wang, Z., Liu, X. The effect of depression on fracture healing and osteoblast differentiation in rats. Neuropsychiatr Dis Treat. 14, 1705-1713 (2018).
  39. Jonsson, T. Micro-CT and deep learning: Modern techniques and applications in insect morphology and neuroscience. Front Insect Sci. 3, (2023).

Przedruki i uprawnienia

Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE

Zapytaj o uprawnienia

Przeglądaj więcej artyków

Micro Computed TomographyKnee AnalysisDunkin Hartley Guinea PigsOsteoarthritisOA ModelIntraarticular InjectionBone Mineral DensityTrabecular Thickness3D ImagingQuantitative AnalysisAseptic TechniqueDrug DistributionStudy VariabilityTherapeutic Agents

This article has been published

Video Coming Soon

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone